Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06722820
PHASE1
Study to Evaluate LPH-5 in Healthy Subjects
Sponsor: Lophora
View on ClinicalTrials.gov
Summary
This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of LPH-5.
Official title: Phase I, First-in-man, Randomised, Placebo-controlled, Single Dose Escalation Study to Investigate the Effects of LPH-5 on Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Parameters in Healthy Participants
Key Details
Gender
MALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2025-04-30
Completion Date
2025-12-31
Last Updated
2024-12-09
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
LPH-5
LPH-5
DRUG
Placebo
Placebo